Gene expression profile in cardiovascular disease and preeclampsia: a meta-analysis of the transcriptome based on raw data from human studies deposited in Gene Expression Omnibus.

INTRODUCTION Cardiovascular disease (CVD) and preeclampsia (PE) share common clinical features. We aimed to identify common transcriptomic signatures involved in CVD and PE in humans. METHODS Meta-analysis of individual raw microarray data deposited in GEO, obtained from blood samples of patients with CVD versus controls and placental samples from women with PE versus healthy women with uncomplicated pregnancies. Annotation of cases versus control samples was taken directly from the microarray documentation. Genes that showed a significant differential expression in the majority of experiments were selected for subsequent analysis. Hypergeometric gene list analysis was performed using Bioconductor GOstats package. Bioinformatic analysis was performed in PANTHER. RESULTS Seven studies in CVD and 5 studies in PE were eligible for meta-analysis. A total of 181 genes were found to be differentially expressed in microarray studies investigating gene expression in blood samples obtained from patients with CVD compared to controls and 925 genes were differentially expressed between preeclamptic and healthy placentas. Among these differentially expressed genes, 22 were common between CVD and PE. DISCUSSION Bioinformatic analysis of these genes revealed oxidative stress, p-53 pathway feedback, inflammation mediated by chemokines and cytokines, interleukin signaling, B-cell activation, PDGF signaling, Wnt signaling, integrin signaling and Alzheimer disease pathways to be involved in the pathophysiology of both CVD and PE. Metabolism, development, response to stimulus, immune response and cell communication were the associated biologic processes in both conditions. Gene set enrichment analysis showed the following overlapping pathways between CVD and PE: TGF-β-signaling, apoptosis, graft-versus-host disease, allograft rejection, chemokine signaling, steroid hormone synthesis, type I and II diabetes mellitus, VEGF signaling, pathways in cancer, GNRH signaling, Huntingtons disease and Notch signaling. CONCLUSION CVD and PE share same common traits in their gene expression profile indicating common pathways in their pathophysiology.

[1]  Szilard Voros,et al.  Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients , 2011, BMC Medical Genomics.

[2]  Khader Shameer,et al.  Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease , 2012, Journal of Clinical Bioinformatics.

[3]  C. Napoli,et al.  Targeting c-Myc, Ras and IGF Cascade to Treat Cancer and Vascular Disorders , 2006, Cell cycle.

[4]  L. Vatten,et al.  Hypertension in Pregnancy and Later Cardiovascular Risk: Common Antecedents? , 2010, Circulation.

[5]  Ping Yang,et al.  Microarray Analysis of Differential Gene Expression Profile in Peripheral Blood Cells of Patients with Human Essential Hypertension , 2011, International journal of medical sciences.

[6]  R. Mitchell.  Learning from rejection: what transplantation teaches us about (other) vascular pathologies. , 2013, Journal of autoimmunity.

[7]  A. Gruslin,et al.  Role of leptin in pregnancy: consequences of maternal obesity. , 2013, Placenta.

[8]  James Lyons-Weiler,et al.  Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. , 2009, Placenta.

[9]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[10]  N. Gleicher.  Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. , 2007, American journal of obstetrics and gynecology.

[11]  P. Øian,et al.  Genome profiles in maternal blood during early onset preeclampsia and towards term , 2010, Journal of perinatal medicine.

[12]  C. Roberts.  IFPA Award in Placentology Lecture: Complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. , 2010, Placenta.

[13]  D. Enquobahrie,et al.  Maternal peripheral blood gene expression in early pregnancy and preeclampsia. , 2011, International journal of molecular epidemiology and genetics.

[14]  L. Chesley,et al.  The remote prognosis of eclamptic women. Sixth periodic report. , 1976, American journal of obstetrics and gynecology.

[15]  J. Habbema,et al.  Risk of cardiovascular disease after pre‐eclampsia and the effect of lifestyle interventions: a literature‐based study , 2013, BJOG : an international journal of obstetrics and gynaecology.

[16]  S. Drăghici,et al.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa , 2013, Journal of perinatal medicine.

[17]  L. Chesley,et al.  The remote prognosis of eclamptic women. , 1976, American heart journal.

[18]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[19]  N. Sattar,et al.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? , 2002, BMJ : British Medical Journal.

[20]  Xiaoshuang Wang,et al.  Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. , 2012, Omics : a journal of integrative biology.

[21]  Y. Cheung,et al.  Fetal Growth and Early Postnatal Growth Are Related to Blood Pressure in Adults , 2000, Hypertension.

[22]  T. Chu,et al.  Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. , 2011, Placenta.

[23]  John L Cleveland,et al.  c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.

[24]  C. Mantzoros,et al.  Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications , 2010, Annals of Internal Medicine.

[25]  J. Gómez-Reino,et al.  Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. , 2011, BioFactors.

[26]  Pascal J. Goldschmidt-Clermont,et al.  Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease , 2009, PloS one.

[27]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. García-García,et al.  What real influence does the proto-oncogene c-myc have in OSCC behavior? , 2011, Oral oncology.

[29]  H. Kurahashi,et al.  Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. , 2007, Placenta.

[30]  S. Tsai,et al.  Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. , 2011, Placenta.

[31]  Anushya Muruganujan,et al.  PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..

[32]  M. Roncalli,et al.  C-myc and tumour suppressor gene product expression in developing and term human trophoblast. , 1994, Placenta.

[33]  B. Fagerberg,et al.  Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes. , 2008, International journal of molecular medicine.

[34]  G. Wallukat,et al.  Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia , 2007, Hypertension.

[35]  H. Raat,et al.  Risk of cardiovascular disease after pre‐eclampsia and the effect of lifestyle interventions: a literature‐based study , 2013, BJOG : an international journal of obstetrics and gynaecology.

[36]  Wei-Yuan Zhang,et al.  Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers , 2009, Journal of perinatal medicine.

[37]  G. Acharya,et al.  Differential placental gene expression in severe preeclampsia. , 2009, Placenta.

[38]  T. Kurz,et al.  Transcriptome Analysis in Patients with Progressive Coronary Artery Disease: Identification of Differential Gene Expression in Peripheral Blood , 2013, Journal of Cardiovascular Translational Research.

[39]  S. Brennecke,et al.  Downstream targets of homeobox gene HLX show altered expression in human idiopathic fetal growth restriction. , 2010, The American journal of pathology.

[40]  S. Thériault,et al.  Linking preeclampsia and cardiovascular disease later in life , 2011, Clinical chemistry and laboratory medicine.

[41]  V. Castracane,et al.  Leptin in Pregnancy , 2000, Biology of reproduction.

[42]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.